Prevalensi Carrier Methicillin Resistant Staphylococcus Aureus (Mrsa) Pada Pasien Penyakit Ginjal Kronik Stadium 5

Texto completo

(1)IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 74. DAFTAR PUSTAKA Abdulrahman IS, Al-Mueilo SH, Bokhary HA, Gani OA & Al-Rubaish LA., 2002. A prospective study of hemodialysis access-related bacterial infections. Journal of Chemotherapy (2002) pp:242-246. Archer NK, Mazaitis MJ & Costerton JW, 2011. Staphylococcus aureus biofilm, properties regulation, and roles in human disease. Virulence. 2(5), pp:445459 Bergheanu SC, Bodde MC, & Jukema JW, 2017. Pathophysiology and treatment of atherosclerosis. Netherland Heart Journal., (25), pp:231-242 Bocher S, Knudsen MA, Guardabassi L, Molbak K, Schouenborg P, Sorum M & Westh H, 2010. The Search and Destroy Strategy prevents spread and longterm carriage of methicillin-resistant Staphylococcus aureus: result from the follow-up screening of a large ST22 (E-MRSA 15) outbreak in Denmark. Clinical Microbiology Infections.; 16(9), pp:1427-34. Bone RC, Sibbald WJ, Sprung CL, 1992. The ACCP-SCCM Consensus Conference on sepsis and organ failure. Chest. 101: 1481-1483. Brown DFJ, 2005. Guideline for the laboratory diagnosis and susceptibility testing of methicillin-resistand Staphylococcus aureus (MRSA). Journal of Anti microbiology Chemotheraphy 56, pp:1000-1018 Celik G, Gulkan A, Dikici N & Gulcan E, 2011, Prevalence of Nasal Staphylococcus aureus Carriage in the Patients Undergoing Hemodialysis and Evaluation of Risk Factors and Laboratory Parameters. Pp:494-498 Carroll KC, Hobden JA & Miller, 2016, Jawetz, Melnick & Adelberg’s Medical Microbiology 27ed, Mcgraw-Hill Education Centers for Disease Control and Prevention, 2014. National Centers for Emerging Zoonotic Infections Diseases. Available at https://www.cdc.gov/hai/pdfs/progress-reports/hai-progress-report.pdf Accessed at January, 06, 2018 Chambers HF, 2004. Antibiotik beta-laktam dan penghambat sintesis dinding sel lainnya. In: BG Katzung, (ed). Farmakologi dasar dan klinik (Basic and Clinical Pharmacology, 8th ed, Salemba Medika, Jakarta, pp. 3-14 Cookson B, Bonten MJM & Mackenzie FM., 2011. Methicillin-resistant Staphylococcus aureus (MRSA): screening and decolonization. International journal of antimicrobial agents, 37(3), pp:195-201 Cosentini R, Tarsia P, Cazzola M & Blasi F, 2004. Treatment of difficult Grampositive infections. In: M Cazzola, F Blasi, S Ewig, eds. Antibiotics and the lung. European Respiratory Monograph, 28(9), pp:113-114 Crossly KB & Archer GL, 1997. Staphylococcus in Human Disease. Churchill Livingstone Datta R, Huang SS, 2008. Risk of Infection and Death due to Methicillin-Resistant Staphylococcus aureus in Long-Term Carriers. Clinical Infection Disease 47:176-81. 74 KARYA AKHIR. PREVALENSI CARRIER METHICILLIN..... EKO OKTIAWAN W., dr.

(2) IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 75. Daum RS, 2007. Skin and soft tissue Infections caused by Methicillin Resistant Staphylococcus aureus. The New England Journal of Medicine 357, pp:380-390 DOI: 10.1056/NEJMcp070747 Daurgirdas J, Blake P& Ing T, 2001. Handbook of Dialysis. Philadelphia: Lippincott Williams & Wilkins. Dellit T, Duchin J, Hofmann J & Olson EG, 2004. Interim guidelines for evaluation and management of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in outpatients setting, September, 1-14. Available from: http://www.metroke/healt/providers/epidemiology/MRSA. Accessed at January, 06, 2018 Dougirdas JT, Blake PG & Ing TS, 2015. Infection. Handbook of Dialysis 5th Ed. A Lippincott William’s & Wilkins handbook. Wotters Kluwar pp:615-663 Federal Bureau Prisons (FBP), 2005. Management of methicillin-resistant Staphylococcus aureus (MRSA) infections. Clinical Practice Guidelines USA, August, 1-34. Available from: http://www.bop.govnews//PDF/mrsa.pdf. Accessed at January, 06, 2018 Fluit AC, Visser MR, Schmitz FJ, 2001. Molecular Detection of Antimicrobial Resistance. CMR 14(4), pp:843-846 Ganong WF, 2005. Review of Medical Physiology, 22nd edition. Mc. Graw-Hill, Boston Guidet B, Soni N, Rocca GD, Kozek S, Vallet B & Annane D, 2010. A balanced view of balanced solutions. Critical Care. 14(5), pp:325 Gupta P, Sarkar S & Das B, 2016. Biofilm, pathogenesis and prevention: a journey to break the wall: a review. Archieves of Microbiology, 198(1), pp:1-15 Hardy KJ, Hawkey PM, Gao F & Oppenheim BA, 2004. Methicillin-resistant Staphylococcus aureus in the critically ill. British Journal of Anaesthesia 92, pp:121-30 Heinrich WL, 2003. Principles and practice of Dialisis, 3rd Ed. Philadelphia: Lippincott Williams & wilkins Hill Pc, Wong CG, Voss LM, Taylor SL, Pottumarthy S, Drinkovic D & Morris AJ, 2001. Prospective study of 125 cases of Staphylococcus aureus bacteremia in children in New Zealand. Pediatric Infectious Disease Journal, volume 20, no 9, pp:868-873 Hiramatsu K, Cui L, Kuroda M & lto T, 2001. The emergence and evolution of Methicillin-resistant Staphylococcus aureus. Trends Microbiology, volume 9, no 10, pp 486-493 cytolitic toxins structure, pore forming mechanism, and organization of the genes. Bioscience, Biotechnology and Biochemistry, Volume 68, no. 5, pp:981-1003. Hoenich NA & Ronco C, 2008. Selecting a Dialysertechnical and Clinical Considerations. In: Nissenson AR, Fine RN, eds. Handbook of Dialysis Therapy. 4th Ed. Philadelphia Elsevier, pp:263-78. KARYA AKHIR. PREVALENSI CARRIER METHICILLIN..... EKO OKTIAWAN W., dr.

(3) IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 76. Hricik DE, 2004. Nonimmunologic Complications of Kidney Transplantation. American Journal of Kidney Disease 43, pp:1135-1137 Inrig JK, Reed SD & Szczech LA, 2006. Relationship between clinical outcomes and vascular access type among hemodialysis patients with Staphylococcus aureus becteriemia. Clinical Journal of American Soc Nephrology 2006, 1, pp:518-24 Johnson RJ, Feehally J & Floege J, 2012. Other Blood and Immune Disorders in Chronic Kidney Disease. Comprehensive Clinical Nephrology. 5th Edition. Elsevier Saunders, pp:975-81 Karanika S, Zervou FN, Zacharioudakis IM, Paudel S & Mylonakis E., 2015. Risk factors for methicillin-resistant Staphylococcus aureus colonization in dialysis patients: a meta-analysis. Journal of Hospital Infection xxx (2015) pp:1-7. Keane WF, Saphiro FL & Raij L, 1977. Incidence and type of infections occurring in Chronic Hemodialysis Patients. Trans ASAIO (23), pp:41-46 K/DOQI, 2002. Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. United States Renal Data System: USRDS 1991 Annual Data Report. Bethesda, Maryland: Institute of Diabetes and Digestive and Kidney Disease Kluytmans JA, Van BA & Verbrugh HA, 1997. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanism and associated risks. Clinical Microbiol Review 10, pp:505-520 Kuntaman K., Hadi U., Setiawan F., Koendori EB., Rusli M., Santosaningsih D & Verbrugh HA. 2016. Prevalence of Methicillin Resistant Staphyllococcus aureus from Nose and Throat of Patients on Admission to Medical Wards of Dr. Soetomo Hospital, Surabaya. Indonesia. Southeast Asian Journal of Tropical Medicine and Public Health 2016, 47 (1), pp:66-70. Kotanko P, Kuhlmann MK & Levin NW, 2010. Hemodialysis: Principles and techniques. In: J Foege, RJ Johnson, J Feehalli, eds. Comprehensive Clinical Nephrology. 4th Ed. St. Louis, Missouri: Elsevier;2010. Pp:10539 Lerma EV, Weir MR, 2017. Immune Dysfunction and Low Grade Persistent Inflammator Practical Guide to Dialysis and How to Manage End Stage Renal Failure. Oxford Handbook 2nd Ed Levi J, Morgan J & Brown E, 2004 A Practical Guide to Dialyis and How to Manage End Stage Renal Failure. Oxford Handbook 2nd Ed Lestari ES, Duerink DO, Hadi U, Severin JA, Nagelkerke NJ, Kuntaman K, Wahjono H, Gardjito W, Soejoenoes A, Van Den Broek PJ, Keuter M,Gyssens IC & Verbrugh HA, 2010. Group Antimicrobial Resistance in Indonesia Prevalence and Prevention. Determinants of resistance in S aureus in the Indonesian population inside and outside hospital. Tropical Medicine Internal Health. 2010 Oct;15(10), pp:1235-43. Lemeshow S, Hosmer D, Klar J & Lwanga S 1990 Adequacy of sample size in health studies. JohnWiley & Sons. KARYA AKHIR. PREVALENSI CARRIER METHICILLIN..... EKO OKTIAWAN W., dr.

(4) IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 77. Lindsay JA, Moore CE, Day NP, Peacock SJ, Witney A, Stabler RA, Husain SE, Butcher PD, & Hinds J. 2006. Microarrays Reveal that Each of the Ten Dominat Lineages of Staphylococcus aureus has a Unique Combination of Surface Associated and Regulatory Genes. Journal of Bacteriology .188(2), pp:669-676 Lowy FD, 1998. Staphylococcus aureus infections. The New England Journal of Medicine 339(8), pp:520-532 Man NK, Jingraff J & Jungers P 1995 Long-term hemodialysis. Kluwer Academic Publishers, Dordrecht-London, pp:78-83 National Nosocomial Infections Surveillance System Report (NNIS), data summary from January 1992 through June 2004, issued October 2004 Available from: https://www.cdc.gov/nhsn/pdfs/datastat/nnis.2004.pdf. Accessed at Jan, 06, 2018 Nathwani D, Morgan M, Masterton R, Dryden M, Cookson B, Frech G & Lewis D, 2008. Guidelines for UK practice for the diagnosis and management of Methicillin-Resistant Staphylococcus aureus (MRSA) infections presenting in the community. Journal of Antimicrobial Chemotherapy 61, pp:976-994 Noskin GA, 2008. Methicillin-resistant Staphylococcus aureus (MRSA). Availableon:http://knol.google.com/../methicillin-resistantstaphylococcus-aureus-mrsa. Accessed at Jan, 06, 2018 Pernefri, 2003. Konsensus Dialisis. Jakarta: Perhimpunan Nefrologi Indonesia Petri WA, 2001. Antimicrobial agents: Penicillin, cephalosporins and other betalactam antibiotics. In: JG Hardman, LE Limbird, AG Gilman, Goodman and Gilman’s the pharmacological basis of therapeutics. 10th ed. McGrawHill, pp:1189-1201 Raygada JL, Donald P & Levine., 2009. Methicillin-Resistant Staphylococcus aureus: A Growing Risk in the Hospital and in the community. American Health and Drug benefits vol 2, pp:86-95. Sai N, Laurent C & Strale H, 2015. Efficacy of the decolonization of Methicillinresistant Staphylococcus aureus carriers in clinical practice. Antimicrobial Resistance and Infection Control, 4(1), p:56. Saxena AK, Panhotra BR, Venkateshappa CK, Sundaram DS, Naguib M, Uzzaman W & Al Mulhim K., 2002. The Impact of Nasal Carriage of Methicillin-Resistant Staphylococcus aureus and Methicillin-Susceptible Staphylococcus aureus (MRSA & MSSA) On Vascular Access-related septicemia among patients with type-II Diabetes on Dialysis. Renal Failure Vol. 24, No 6, pp:763-777. Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, Rubenfield G, Kahn JM, Hari MS, Singer M, Deutschman CS, Escobar GJ, Angus DC, 2016. Assessment of Clinical Criteria for Sepsis for the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis3). The Journal of the American Medical Association. 315(8): 762-774. KARYA AKHIR. PREVALENSI CARRIER METHICILLIN..... EKO OKTIAWAN W., dr.

(5) IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 78. Severin A, Lestari E.S, Kuntaman, Melles DC, Pastink M, Peeters JK, Snijders SV, Hadi U, Duerink DO, Belkum A. & Verbrugh HA, 2008. Unusually high prevalence of Panton-Valentine leukocidin genes among Methicillinsensitive Staphylococcus aureus strains carried in the Indonesian population. Journal of Clinical Microbiology, Vol 46, Santosaningsih D. Santoso, S., Budayanti NS, Kuntaman K, Lestari ES, Farida H, Hapsari R, Hadi P, Winarto W, Milheiric ̧OC, Maquelin K, DWillemseErix, van Belkum A, Severin JA, & Verbrugh HA, 2014. Epidemiology of Staphylococcus aureus, Harboring the mecA or Panton-Valentine Leukocidin Genes in Hospitals in Java and Bali, Indonesia. American Journal of Tropical Medicine Hygiene., 90(4), 2014, pp:728–734. Sharif A, 2008. Community-Acquired Methicillin -Resistant Staphylococcus aureus (CA-MRSA) Colonization and Infection in Intravenous and Inhalational Opiate Drug Abusers. Exp Biol Medicine 233, pp:874-880 Sharma G, Sharma S & Sharma P, 2016. Escherichia coli biofilm: development and therapeutic strategies. Journal of Applied Microbiology, 121(2), pp:309-319. Steven RD, Huff JS, Weingart SD, & Smith WS, 2012. Emergency neurological life support: Approach to the patient with coma. Neurocritical Care, 17(S1) pp:54-9 Stevens LA, Coresh J & Selvin E, 2009. Prevalence of Chronic Kidney Disease In the United States. JAMA, 298, pp:2038-2047 Stone JCV, 1994. Hemodialysis apparatus. In (JT Daugirdas, TS Ing, eds). Handbook of dialysis, 2nd edition. London: little, Brown and Company, pp:30-52 Tenover FC & Hughes JM, 1996. The challenges of emerging infectious disease. Development and Spread of Multiply Resistant Bacterial Pathogen. Jama 275:300-304 Todar K, 2009, Staphilococcus and Staphylococcus Disease. Available at http://www.textbookofbacteriology.net/themicrobialworld/staph.html. Accessed at Jan, 06, 2018 Tong SYC, David JS., Eichenberger E., Holland TL & Fowler VG. 2015. Staphylococcus aureus infections Epidemiology, pathophysiology, clinical manifestations, and management. Clinical Microbiology Reviews, Volume 28, No 3, pp:603-661 Utay NS, Roque A, Timmer JK, Morcock DR, DeLeage C, Somasunderam A, Weintrob AC, Agan BK, Estes JD, Crum-Cianflone NF & Douek DC.,2016. MRSA Infections in HIV-Infected People Are Associated with Decreased MRSA-Specific Th1 Immunity. PLOS Pathogens/ DOI:10.1371/journal.ppat.1005580 Vandenesch FT, Naimi MC, Enright G, Lina GR, Nimmo H, Heffernan N, Liassine M, Bes T, Greenland ME, Reverdy & Etienne J, 2003. Community-acquired methicillin resistant Staphylococcus aureus carrying. KARYA AKHIR. PREVALENSI CARRIER METHICILLIN..... EKO OKTIAWAN W., dr.

(6) IR - PERPUSTAKAAN UNIVERSITAS AIRLANGGA. 79. Panton-Valentine leucocidin genes: worldwide emergence. Emergence Infections Disease. (9), pp:978-984. Vandecasteele SJ, Boelaert JR & Vriese SD., 2009. Staphylococcus aureus Infections in Hemodialysis: What a Nephrologist Should Know. Clinical Journal American Society Nephrology 4 pp:1388-1400 Vanholder R, Schepers E, Meert N & Lameire N, 2006. What is uremia? Retention vs Oxidation Blood Purif. 2006;24, pp:33-38 Vasudevan R, 2014. Biofilms: Microbial Cities of Scientific Significance. Journal Microbiol Experiment, 1(3), pp:1-16 Vincent JL, Moreno R, Takala J, Willatts S, De Mendon A, Bruining H, Reinhart CK, Suter PM, Thijs LG, 1996. Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Medicine. 22(7): 707-710. Wang CY, Wu VC, Wang WJ, Lin YF, Lin YH, Chen YM, Su CT, Wang JY, Wu KD & Hsueh PR, 2012. Risk factors for nasal carriage of methicillinresistant Staphylococcus aureus among patients with end-stage renal disease in Taiwan. Journal of the Formosan Medical Association (2012) 111, 14-18 Wertheim HFL, Melles DC, Vos MC, Leeuwen W, van BelKum A, Vebrugh HA, & Nouwen JL, 2005. The Role of Nasal Carriage in Staphylococcus aureus Infections. The Lancer Infectious Diseases, Vol 5, No 12, pp:751-762 Yang ES, Tan J, Eells S, Rieg G, Tagudar G & Miller LG. 2010. Body Site Colonization in Patients with Community-Associated MethicillinResistant Staphylococcus aureus and other types of S. aureus skin infections. Clinical Microbiology and Infection; Vol.16, Issue 5, pp:425431. Yamamoto T, Nishiyama A, Takano T, Yabe S, Higuchi W, Razvina O & Shi D, 2010. Community-acquired methicillin-resistant Staphylococcus aureus: community transmission, pathogenesis, and drug resistance. Journal Infections Chemotherapy 16, pp:225-254 Yeoh LY, Tan FL, Willis GC & Ooi ST., 2014. Methicillin-resistant Staphylococcus aureus carriage in hospitalized chronic hemodialysis patients and its predisposing factors. Hemodialysis International 2014, pp:142-147 Zawada ET, 1994. Indication for dialysis. In (JT Daugirdas, TS Ing, eds). Handbook of dialysis, 2nd ed. London: little, Brown and Company, 39 Management by Laboratory Methods, 20th Ed, WB Saunders, Philadelphia, pp:974-989.. KARYA AKHIR. PREVALENSI CARRIER METHICILLIN..... EKO OKTIAWAN W., dr.

(7)